"Today marks the dawn of the AI era at the FDA[. W]ith the release of Elsa, AI is no longer a distant promise but a dynamic force enhancing and optimizing the performance and potential of every ...

The FDA regulates products that account for one-fifth of American consumer spending—everything from lettuce to vapes to pet ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...

The FDA has launched a pilot program using generative AI to help expedite the review of drug and device applications, part of a sweeping modernization effort by the agency. The initiative, led by FDA ...

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...

The FDA announced last week it launched Elsa, an AI tool designed to help employees work better. AI also is impacting ...

Elsa” is the FDA’s new anthropomorphized AI tool which, the FDA hopes, will speed up clearances, licenses, and approvals ...